Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-25-000015
Filing Date
2025-11-04
Accepted
2025-11-04 16:03:53
Documents
62
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20250930.htm   iXBRL 10-Q 1106266
2 EX-10.1 a101.htm EX-10.1 23390
3 EX-10.2 a102.htm EX-10.2 25433
4 EX-31.1 fold-09302025xex311.htm EX-31.1 10871
5 EX-31.2 fold-09302025xex312.htm EX-31.2 10942
6 EX-32.1 fold-09302025xex321.htm EX-32.1 8411
  Complete submission text file 0001178879-25-000015.txt   5889352

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20250930.xsd EX-101.SCH 31253
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20250930_cal.xml EX-101.CAL 66028
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20250930_def.xml EX-101.DEF 114190
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20250930_lab.xml EX-101.LAB 527032
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20250930_pre.xml EX-101.PRE 336997
65 EXTRACTED XBRL INSTANCE DOCUMENT fold-20250930_htm.xml XML 851763
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 251448867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)